Encelo Laboratories

Universal access to primary cells

Company Details

We are solving a patient-specific cell sourcing problem by optimising the current method for cell isolation and preservation from urine samples, to allow shipment of these cells directly from individuals of interest to a researcher, Encelo Laboratories is developing a point of care device, a single use cup, that will allow researchers in academia, pharma and biotech, direct access to cells from a desired population of donors, for a variety of downstream applications, such as disease modelling, drug screens, biomarker discovery, iPSC reprogramming.

  • Encelo Laboratories Video 1
  • Encelo Laboratories Image 1

Company People

Katia Nazmutdinova

Katia Nazmutdinova
CSO

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities.